Biotechayur Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 4.63 M
as on 17-07-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -9.68%
(FY 2023)
- Profit 17.01%
(FY 2023)
- Ebitda 17.05%
(FY 2023)
- Net Worth -10.97%
(FY 2023)
- Total Assets 1.25%
(FY 2023)
About Biotechayur
The Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.63 M, as per Ministry of Corporate Affairs (MCA) records.
Abhay Pati and Sitaram Sarangi serve as directors at the Company.
- CIN/LLPIN
U22211OR2006PTC008641
- Company No.
008641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Balasore, Orissa, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biotechayur Private Limited offer?
Biotechayur Private Limited offers a wide range of products and services, including Edible Oil & Allied Products, Fish Oil, Ayurvedic & Herbal Extracts, Fruit Extracts, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Biotechayur?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Pati  | Managing Director | 27-Mar-2006 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sitaram Sarangi  | Director | 01-Oct-2011 | Current |
Financial Performance and Corporate Structure Insights of Biotechayur.
Biotechayur Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.68% decrease. The company also saw a substantial improvement in profitability, with a 17.01% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotechayur?
In 2023, Biotechayur had a promoter holding of 94.20% and a public holding of 5.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
8 years 6 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotechayur?
Biotechayur has a workforce of 13 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Feb 24, 2011, Biotechayur has raised a total of ₹ 9.93 Cr, with the most recent deal valued at ₹ 2.46 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
